Moleculin Biotech, Inc. Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued
Moleculin Biotech, Inc. (MBRX) had Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued of $0 as of 2017-12-31, per its 10-K filed 2018-03-28.
Discontinued › Balance Sheet › Liabilities
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued · last filed 2018-03-28
- 2017-12-31: Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued $0.00.
- 2016-12-31: Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued $0.00.
| Period end | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued |
|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-03-28 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |